These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18030459)

  • 21. Wu-Ling-San formula inhibits the crystallization of calcium oxalate in vitro.
    Chen YC; Ho CY; Chen LD; Hsu SF; Chen WC
    Am J Chin Med; 2007; 35(3):533-41. PubMed ID: 17597511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical value of crystalluria study].
    Daudon M; Jungers P; Lacour B
    Ann Biol Clin (Paris); 2004; 62(4):379-93. PubMed ID: 15297232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
    Kalaiselvi P; Udayapriya KL; Selvam R
    BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of various calcium intakes on calcium-oxalate crystalluria in rats on sodium-oxalate diet.
    da Silva SL; Hennequin C; Droz D; Bader C; Daudon M; Drüeke T; Lacour B
    Nephrol Dial Transplant; 1994; 9(8):1090-6. PubMed ID: 7800206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
    Khan SR; Glenton PA; Backov R; Talham DR
    Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal growth of calcium oxalate in urine of stone-formers and normal controls.
    Achilles W; Dekanić D; Burk M; Schalk C; Tucak A; Karner I
    Urol Res; 1991; 19(3):159-64. PubMed ID: 1887523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi.
    Frochot V; Daudon M
    Int J Surg; 2016 Dec; 36(Pt D):624-632. PubMed ID: 27847293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium oxalate crystallisation kinetics and the effects of calcium and gamma-carboxyglutamic acid.
    Nishio S; Kavanagh JP; Faragher EB; Garside J; Blacklock NJ
    Br J Urol; 1990 Oct; 66(4):351-6. PubMed ID: 2224428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary glycosaminoglycans and glycoproteins in a calcium oxalate crystallization system.
    Poon NW; Gohel MD
    Carbohydr Res; 2012 Jan; 347(1):64-8. PubMed ID: 22119438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium carbonate crystals promote calcium oxalate crystallization by heterogeneous or epitaxial nucleation: possible involvement in the control of urinary lithogenesis.
    Geider S; Dussol B; Nitsche S; Veesler S; Berthézène P; Dupuy P; Astier JP; Boistelle R; Berland Y; Dagorn JC; Verdier JM
    Calcif Tissue Int; 1996 Jul; 59(1):33-7. PubMed ID: 8661982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium oxalate crystallization kinetics at different concentrations of human and artificial urine, with a constant calcium to oxalate ratio.
    Kavanagh JP; Jones L; Rao PN
    Urol Res; 1999 Aug; 27(4):231-7. PubMed ID: 10460891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new approach to studying inhibitors of calcium oxalate crystal growth.
    Hennequin C; Lalanne V; Daudon M; Lacour B; Drueke T
    Urol Res; 1993 Mar; 21(2):101-8. PubMed ID: 8389069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
    Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
    Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules.
    Wesson JA; Worcester EM; Wiessner JH; Mandel NS; Kleinman JG
    Kidney Int; 1998 Apr; 53(4):952-7. PubMed ID: 9551403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of osteopontin on calcium oxalate crystal formation.
    Konya E; Umekawa T; Iguchi M; Kurita T
    Eur Urol; 2003 May; 43(5):564-71. PubMed ID: 12706004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of various modifiers on calcium oxalate crystallization.
    Kulaksizoglu S; Sofikerim M; Cevik C
    Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of pH on the risk of calcium oxalate crystallization in urine.
    Berg C; Tiselius HG
    Eur Urol; 1986; 12(1):59-61. PubMed ID: 3948899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibitory activity of urinary macromolecule upon calcium oxalate crystal aggregation using an aggregometer].
    Ebisuno S; Miyata K; Kohjimoto Y; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1993 Feb; 84(2):339-44. PubMed ID: 8464186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.